Skip to content
Politically.com Search all
Menu

2026 · 2nd Quarter (Apr 1 - June 30)

COHERUS BIOSCIENCES, INC.

Filed by COHERUS BIOSCIENCES.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-09-16 06:26:08 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 28, 2026
Income
Not reported
Expenses
$95,000.00
Filing UUID
6137b67d-e3c2-468f-b74d-cc5717094210
Termination date
Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to oncology, Medicare coverage, domestic production of essential drugs, supply chain security, PILLS Act, Biosecure Act and efforts to onshore manufacturing, Loans and grants for biologic production in America

GOV · Government Issues

Issues related to drug development, oncology, IRA implementation, supply chain security, BIOSECURE as a policy matter, PILLS Act, and domestic production of essential drugs. Strategic National Stockpile of acute radiation syndrome medical counter measures. Administration for Strategic Preparedness & Response.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.